Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Hum Reprod. 2024 Jun 3;39(6):1323-1335. doi: 10.1093/humrep/deae077.
Does medically assisted reproduction (MAR) use among cisgender women differ among those with same-sex partners or lesbian/bisexual identities compared to peers with different-sex partners or heterosexual identities?
Women with same-sex partners or lesbian/bisexual identities are more likely to utilize any MAR but are no more likely to use ART (i.e. IVF, reciprocal IVF, embryo transfer, unspecified ART, ICSI, and gamete or zygote intrafallopian transfer) compared to non-ART MAR (i.e. IUI, ovulation induction, and intravaginal or intracervical insemination) than their different-sex partnered and completely heterosexual peers.
Sexual minority women (SMW) form families in myriad ways, including through fostering, adoption, genetic, and/or biological routes. Emerging evidence suggests this population increasingly wants to form genetic and/or biological families, yet little is known about their family formation processes and conception needs.
STUDY DESIGN, SIZE, DURATION: The Growing Up Today Study is a US-based prospective cohort (n = 27 805). Participants were 9-17 years of age at enrollment (1996 and 2004). Biennial follow-up is ongoing, with data collected through 2021.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Cisgender women who met the following criteria were included in this sample: endorsed ever being pregnant; attempted a pregnancy in 2019 or 2021; and endorsed either a male- or female-sex partner OR responded to questions regarding their sexual identity during their conception window. The main outcome was any MAR use including ART (i.e. procedures involving micromanipulation of gametes) and non-ART MAR (i.e. nonmanipulation of gametes). Secondary outcomes included specific MAR procedures, time to conception, and trends across time. We assessed differences in any MAR use using weighted modified Poisson generalized estimating equations.
Among 3519 participants, there were 6935 pregnancies/pregnancy attempts and 19.4% involved MAR. A total of 47 pregnancies or pregnancy attempts were among the same-sex partnered participants, while 91 were among bisexual participants and 37 among lesbian participants. Participants with same-sex, compared to different-sex partners were almost five times as likely to use MAR (risk ratio [95% CI]: 4.78 [4.06, 5.61]). Compared to completely heterosexual participants, there was greater MAR use among lesbian (4.00 [3.10, 5.16]) and bisexual (2.22 [1.60, 3.07]) participants compared to no MAR use; mostly heterosexual participants were also more likely to use ART (1.42 [1.11, 1.82]) compared to non-ART MAR. Among first pregnancies conceived using MAR, conception pathways differed by partnership and sexual identity groups; differences were largest for IUI, intravaginal insemination, and timed intercourse with ovulation induction. From 2002 to 2021, MAR use increased proportionally to total pregnancies/pregnancy attempts; ART use was increasingly common in later years among same-sex partnered and lesbian participants.
LIMITATIONS, REASONS FOR CAUTION: Our results are limited by the small number of SMW, the homogenous sample of mostly White, educated participants, the potential misclassification of MAR use when creating conception pathways unique to SMW, and the questionnaire's skip logic, which excluded certain participants from receiving MAR questions.
Previous studies on SMW family formation have primarily focused on clinical outcomes from ART procedures and perinatal outcomes by conception method, and have been almost exclusively limited to European, clinical samples that relied on partnership data only. Despite the small sample of SMW within a nonrepresentative study, this is the first study to our knowledge to use a nonclinical sample of cisgender women from across the USA to elucidate family formation pathways by partnership as well as sexual identity, including pathways that may be unique to SMW. This was made possible by our innovative approach to MAR categorization within a large, prospective dataset that collected detailed sexual orientation data. Specifically, lesbian, bisexual, and same-sex partnered participants used both ART and non-ART MAR at similar frequencies compared to heterosexual and different-sex partnered participants. This may signal differential access to conception pathways owing to structural barriers, emerging conception trends as family formation among SMW has increased, and a need for conception support beyond specialized providers and fertility clinics.
STUDY FUNDING/COMPETING INTEREST(S): The research reported in this publication was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health (NIH), under award number R01MD015256. Additionally, KRSS is supported by NCI grant T32CA009001, AKH by the NCI T32CA057711, PC by the NHLBI T32HL098048, BM by the Stanford Maternal Child Health Research Institute Clinical Trainee Support Grant and the Diversity Fellowship from the American Society for Reproductive Medicine Research Institute, BGE by NICHD R01HD091405, and SM by the Thomas O. Pyle Fellowship through the Harvard Pilgrim Health Care Foundation and Harvard University, NHLBI T32HL098048, NIMH R01MH112384, and the William T. Grant Foundation grant number 187958. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The first author recently had a leadership role in the not-for-profit program, The Lesbian Health Fund, a research fund focused on improving the health and wellbeing of LGBTQ+ women and girls. The fund did not have any role in this study and the author's relationship with the fund did not bias the findings of this manuscript.
N/A.
与不同性伴侣或异性恋身份的同龄人相比,具有同性伴侣或女同性恋/双性恋身份的顺性别女性在使用任何辅助生殖技术(MAR)方面是否存在差异?
与非辅助生殖技术 MAR(即 IUI、排卵诱导、阴道内或宫颈内授精)相比,具有同性伴侣或女同性恋/双性恋身份的女性更有可能利用任何 MAR,但她们使用辅助生殖技术(ART)(即 IVF、互惠 IVF、胚胎移植、未指定的 ART、ICSI 和配子或受精卵输卵管内转移)的可能性并不更高。
性少数群体女性(SMW)以多种方式组建家庭,包括寄养、收养、遗传和/或生物途径。新出现的证据表明,这一人群越来越希望组建遗传和/或生物家庭,但对他们的家庭组建过程和受孕需求知之甚少。
研究设计、规模、持续时间:“今天成长研究”是一项基于美国的前瞻性队列研究(n=27805)。参与者在入组时年龄为 9-17 岁(1996 年和 2004 年)。目前正在进行两年一次的随访,数据收集截止到 2021 年。
参与者/材料、设置、方法:符合以下标准的顺性别女性被纳入本样本:曾怀孕;2019 年或 2021 年尝试怀孕;并拥有男性或女性伴侣,或在受孕窗口期回答了有关其性身份的问题。主要结果是任何 MAR 的使用情况,包括 ART(即涉及配子微操作的程序)和非-ART MAR(即不涉及配子操作的程序)。次要结果包括特定的 MAR 程序、受孕时间和随时间的趋势。我们使用加权修正泊松广义估计方程评估任何 MAR 使用的差异。
在 3519 名参与者中,有 6935 次妊娠/妊娠尝试,其中 19.4%涉及 MAR。共有 47 次妊娠或妊娠尝试发生在同性伴侣参与者中,91 次发生在双性恋参与者中,37 次发生在女同性恋参与者中。与不同性伴侣相比,具有同性伴侣的参与者使用 MAR 的可能性几乎是其五倍(风险比[95%CI]:4.78[4.06,5.61])。与完全异性恋参与者相比,女同性恋(4.00[3.10,5.16])和双性恋(2.22[1.60,3.07])参与者的 MAR 使用率更高,而没有 MAR 使用;大多数异性恋参与者也更有可能使用 ART(1.42[1.11,1.82])而不是非-ART MAR。在使用 MAR 受孕的首次妊娠中,伴侣关系和性身份群体的受孕途径存在差异;在 IUI、阴道内授精和定时性交伴排卵诱导方面,差异最大。从 2002 年到 2021 年,MAR 的使用比例与总妊娠/妊娠尝试成正比;在具有同性伴侣和女同性恋参与者的后期,ART 的使用越来越普遍。
局限性、谨慎的原因:我们的结果受到性少数群体女性数量较少、主要为白人、受过教育的参与者的同质样本、为 SMW 独特的受孕途径创建 MAR 使用情况时可能存在的错误分类以及问卷的跳过逻辑的限制,这些限制将某些参与者排除在接受 MAR 问题之外。
以前关于性少数群体家庭形成的研究主要集中在 ART 程序的临床结果和受孕方法的围产期结果上,并且几乎完全局限于仅依赖伙伴关系数据的欧洲临床样本。尽管 SMW 样本量较小,但这是我们所知的第一项使用来自美国各地的非代表性样本的顺性别女性的研究,以确定伴侣关系以及性身份的家庭形成途径,包括可能仅适用于 SMW 的途径。这是通过我们在一个大型前瞻性数据集内对 MAR 进行分类的创新方法实现的,该数据集详细收集了性取向数据。具体而言,与异性恋和不同性伴侣相比,女同性恋、双性恋和同性伴侣参与者使用 ART 和非-ART MAR 的频率相似。这可能表明由于结构障碍、SMW 家庭形成的新兴受孕趋势以及对除专门提供者和生育诊所之外的受孕支持的需求,导致了对受孕途径的不同访问。
研究资金/利益冲突:本报告所述的研究由美国国立卫生研究院(NIH)下属的少数民族健康和健康差异研究所(NIMHD)资助,资助号为 R01MD015256。此外,KRSS 由 NCI 授予 T32CA009001,AKH 由 NCI T32CA057711,PC 由 NHLBI T32HL098048,BM 由斯坦福母婴健康研究学会临床研究员支持奖学金和美国生殖医学研究学会多样性奖学金,BGE 由 NICHD R01HD091405,SM 由哈佛朝圣者健康保健基金会和哈佛大学的 Thomas O. Pyle 奖学金以及 NHLBI T32HL098048、NIMH R01MH112384 和 William T. Grant 基金会资助 187958 号资助。内容仅由作者负责,不一定代表 NIH 的官方观点。第一作者最近在非营利组织“女同性恋健康基金”(The Lesbian Health Fund)中担任领导职务,该基金是一个专注于改善 LGBTQ+女性和女孩健康和福祉的研究基金。该基金在此项研究中没有任何作用,作者与该基金的关系也没有影响本手稿的研究结果。
无。